Lunai Bioworks
(NASDAQ) LNAI
Lunai Bioworks Financials at a Glance
Market Cap
$10.38M
Revenue (TTM)
$20.94K
Net Income (TTM)
-$128.28M
EPS (TTM)
-$61.29
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$2.26
Volume
26,349.26
Open
$2.25
Price
$2.26
Volume
26,349.26
Open
$2.25
Previous Close
$2.29
Daily Range
$2.25 - $2.37
52-Week Range
$1.21 - $33.50
Estimated Earnings Date
May 15, 2026
Dividend
$0.00
Beta (Volatility)
1.32 (Average)
Price
$2.26
Volume
26,349.26
Open
$2.25
Previous Close
$2.29
Daily Range
$2.25 - $2.37
52-Week Range
$1.21 - $33.50
Estimated Earnings Date
May 15, 2026
LNAI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lunai Bioworks
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
David Weinstein
Website
www.renovarogroup.comHeadquarters
Los Angeles, CA 90067, US
LNAI Financials
Key Financial Metrics (TTM)
Gross Margin
-4%
Operating Margin
-470%
Net Income Margin
-6126%
Return on Equity
-325%
Return on Capital
1%
Return on Assets
-13%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.38M
Shares Outstanding
4.53M
Volume
26.35K
Avg. Volume
2.64M
Financials (TTM)
Gross Profit
-$129.09K
Operating Income
-$18.55M
EBITDA
-$18.42M
Operating Cash Flow
-$7.87M
Capital Expenditure
-$3.00
Free Cash Flow
-$7.87M
Cash & ST Invst.
$480.55K
Total Debt
$10.17M
Lunai Bioworks Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.94K
N/A
Gross Profit
$9.94K
N/A
Gross Margin
47.47%
N/A
Market Cap
$10.38M
N/A
Market Cap/Employee
$358.02K
N/A
Employees
29
N/A
Net Income
-$2.57M
-1459.3%
EBITDA
-$1.42M
-445.6%
Quarterly Fundamentals
Total Cash
$3.16M
+93.2%
Total Debt
$1.41M
-79.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$131.32K
-73.6%
Short Term Debt
$1.28M
-80.4%
Return on Assets
-13.01%
N/A
Return on Invested Capital
1.04%
N/A
Free Cash Flow
-$1.03M
+31.0%
Operating Cash Flow
-$1.03M
+31.0%